Group 2 innate lymphoid cells: Where are we 15 years out?
Journal of Allergy and Clinical Immunology · 2026-07 · 158 (1) · 1-11
DOI: 10.1016/j.jaci.2026.04.013 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-07. Verfasst von Taylor A Doherty. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Medicine, University of California, San Diego, and Veterans Affairs San Diego Health Care System, L…. Hauptthemen laut MEDLINE: Immunity, Innate, Lymphocytes, Rhinosinusitis, Asthma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, NIAID.
Abstract (Originalsprache)
Over the past two decades, innate lymphoid cells (ILCs) have emerged as critical early responders in immune responses, orchestrating inflammation through cytokine production independent of antigen specificity. Early after their discovery, Group 2 ILCs (ILC2s) were found to produce high levels of IL-5 and IL-13 upon stimulation by epithelial-derived alarmins IL-33, IL-25, and thymic stromal lymphopoietin (TSLP). Since then, a robust amount of literature has emerged that places ILC2s as central to type 2 inflammatory diseases, including rhinosinusitis and asthma. Recent work continues to rapidly expand our knowledge of how ILC2s are modulated and contribute to immune disease and maintain homeostasis. This review will focus on recent updates to our understanding of ILC2s in the context of neural and endocrine modulation, memory/trained immunity, cellular fate/plasticity, and adaptive type 2 responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Department of Medicine, University of California, San Diego, and Veterans Affairs San Diego Health Care System, La Jolla, Calif. Electronic address: tdoherty@health.ucsd.edu.
Förderung
- BLRD VA
- NIAID NIH HHS
- NIAID
- Department of Veterans Affairs
Zitieren
APA
Doherty, T. A. (2026). Group 2 innate lymphoid cells: Where are we 15 years out?. Journal of Allergy and Clinical Immunology, 158(1), 1-11. https://doi.org/10.1016/j.jaci.2026.04.013
Vancouver
Doherty TA. Group 2 innate lymphoid cells: Where are we 15 years out?. Journal of Allergy and Clinical Immunology. 2026;158(1):1-11. doi:10.1016/j.jaci.2026.04.013
BibTeX
@article{Doherty2026,
author = {Doherty, Taylor A},
title = {Group 2 innate lymphoid cells: Where are we 15 years out?},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
volume = {158},
number = {1},
pages = {1--11},
doi = {10.1016/j.jaci.2026.04.013}
}
EUVIMED